Wednesday, 08 April 2020

Australia News

  • Scientists discover childhood epilepsy genes

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 13 Aug, 2013

    Singapore: National Institute of Health (NIH)-funded genetic study of childhood epilepsies has linked two new genes to severe forms of disease and provides a novel strategy for identifying ...Read more

  • CSL hemophilia therapy gets orphan drug status

    Australia |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 11 Jun, 2012

    Singapore: CSL Behring's novel recombinant fusion protein linking coagulation factor IX with recombinant albumin (rIX-FP), which can be used for the treatment of Hemophilia B, has been gran...Read more

  • Genetic Technologies Announces Key Managerial Appointment

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Genetic Technologies announced the appointment of Mr. Mark Ostrowski as Senior Vice President Sales and Marketing Molecular Diagnostics. In this role, Mark will be responsible...Read more

  • IMCD acquires Aussie pharma distributor

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 02 Aug, 2013

    Singapore: Global distribution firm IMCD Group has acquired Capitol Ingredients Australia, a Sydney headquartered speciality ingredients distributor focused on the nutraceuticals, personal ...Read more

  • Bionomics, CTx advance in growth factor research

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 17 May, 2013

    Singapore: Bionomics joint program with the Australian Partner consortium Co-operative Research Centre for Cancer Therapeutics (CTx) has reached a proof of concept milestone in the discover...Read more

  • Ansell Completes Acquisition of Comasec SAS

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Ansell, global leader in protective solutions, has successfully concluded its acquisition of Comasec SAS, having received regulatory approval for the transaction. The deal is va...Read more

  • Commercialisation Australia grants $1 mn to Proteomics

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 23 Aug, 2012

    Singapore: Commercialisation Australia has awarded Proteomics International, a life sciences company based in Perth, with $1 million grant to develop its biomarkers for diabetic kidney dise...Read more

  • Vaccines do not cause autism: Study

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 30 May, 2014

    Singapore: Researchers from the University of Sydney, have dismissed any link between development of autism and childhood vaccination programs. In a study that covered more than 1.25 milli...Read more

  • Cancer researcher gets Aus academy's highest accolade

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 09 Nov, 2012

    Singapore: Cancer researcher Professor Jerry Adams has won the Australian Academy of Science's most prestigious award for biological sciences, the Macfarlane Burnet Medal. Joint head of th...Read more

  • Aussie drug delivery firm raises $19.3 mn

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 15 Jul, 2014

    Singapore: Australian drug delivery company, Phosphagenics, has raised $19.3 million via a placement of $16.3 million to institutional and sophisticated investors in Europe, USA, Asia and A...Read more

  • AusBiotech, Hong Kong firm to partner on investment events

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 03 Oct, 2012

    Singapore: Biotechnology industry group, AusBiotech and Beacon Events, organiser of the largest resource sector investor event in the Asia Pacific Region called Mines and Money, announced a...Read more

  • University of Sydney makes big takeover

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 16 Jul, 2014

    Singapore: In a bid to ahead a major initiative towards the advancement of fertility research and treatment, the University of Sydney has announced a big take over. It said in an official s...Read more

  • PolyActiva raises US$9.4 mn in Series B venture funding

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: PolyActiva announced today that it has raised US$9.4 million (AU$9.2 million) in a Series B financing round from a consortium of investors including Medical Research Commercialis...Read more

  • Viralytics gets positive prelim data for Cavatak

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 29 Nov, 2012

    Singapore: Viralytics, a company listed in the Australian Securities Exchange, has received positive preliminary data in bladder cancer in its collaboration with Professor Hardev Pandha's ...Read more

  • Starpharma's formulation shows improvement in crop protection

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Starpharma Holdings announced that its new agrochemical dendrimer formulations have shown further improved features compared to commercially available products. Starpharma has ...Read more

  • New South Wales gets Medical Devices Fund

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: New South Wales (NSW) Health and Medical Research Strategic Review has established Medical Devices Fund (MDF) of $5 million per annum to contribute to the discovery and applicati...Read more

  • Ansell, Ramsay enter global purchasing agreement

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Australia-based healthcare safety solutions provider, Ansell, entered into a multi-year purchasing agreement with Ramsay Health Care, one of the largest private hospital groups i...Read more

  • Algae.Tec biofuels technology to feature at 2012 ILA Berlin airshow

    Australia |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2012

    Singapore: Sourcing sustainable aviation biofuels at-scale is a major theme at this year's ILA Berlin Airshow and its dedicated Alternative Aviation Fuels Pavilion, designed to showcase th...Read more